drugset / Trial / NCT03312361

Assessing Air Travel Safety in Neuromuscular Dystrophy: Standard Versus Prolonged High Altitude Simulation Tests

NCT03312361

Completed 23 enrolled The Hospital for Sick Children
NaSingle-groupOpen-labelDiagnostic

Summary

To determine if a prolonged high altitude simulation test (HAST) lasting two hours, identifies more patients at risk of respiratory failure than the standard HAST lasting 20 minutes, in patients with neuromuscular disease (NMD) and severe pulmonary restriction. To evaluate the safety of supplemental oxygen administered in those with a positive HAST in the NMD population.

Timeline

Start
2016-04-01
Primary completion
2018-04-01
Completion
2018-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 15 % Inhaled